NL-OMON42581已完成不适用
Effects of collagen peptide supplementation on knee JOINT discomfort during and after repetitive low-INtensity exercise - JOIN(T)-I
Fysiologie0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •o Registration for the Nijmegen Four Days Marches 2016
- •o Self-reported activity-related knee discomfort (VAS score >=1)
- •o Between 50 and 75 years of age
- •o Willingness to provide written consent after proper information about the study objectives and procedures.
排除标准
- •o A known systemic joint or muscle disease
- •o Individuals that follow a low protein diet for medical reasons due to known kidney disease.
- •o Disease influencing the uptake of protein (i.e. inflammatory bowel disease, Crohn*s disease)
- •o Vegetarian diet
- •o Diabetes mellitus (type 1 and type 2)
- •o Recent knee surgery (< 6 months)
- •o Use of statins or other medicines that influence muscle health
- •o Use of other dietary supplements for joint health (i.e. glucosamine, chondroitin)
研究者
相似试验
招募中
不适用
Effects of protein supplementation on knee complaints during and after repetitive walking exerciseKnee joint discomfort in rest, during and after low-intensity exerciseNL-OMON25107Radboudumc Nijmegen, Netherlands200
已完成
不适用
Effects of collagen peptide supplementation combined with high-load resistance training on structural and functional Achilles tendon propertiesHealthy individualsDRKS00015998Institut für Sport und Sportwissenschaft, Albert-Ludwigs-Universität Freiburg50
尚未招募
不适用
The effect of collagen supplementation on collagen metabolism after total hip arthroplasty.NL-OMON27884Maastricht University40
招募中
不适用
The effect of collagen supplementation on collagen metabolism after total hip arthroplasty.Hip osteoarthritisNL-OMON54316niversiteit Maastricht40
已完成
不适用
Effect of collagen peptide intake on the leg pain onset in the training phase of long-distance runnersHealthy long-distance runnersJPRN-UMIN000023033itta Gelatin Inc. Peptide Division.60
